CompoAtlas

Evening Primrose Oil 1000 mg + E200 IU

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal composition not provided.

Non-medicinal ingredients

Eau purifiée, Glycérine, Gélatine

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Capsule1 Tous les jours
AdultesNot specified1 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of essential fatty acids for the maintenance of good health. Source of linoleic acid for the maintenance of good health. Source of omega-6 fatty acids for the maintenance of good health. A factor in the maintenance of good health. Antioxidant for good health. Contributes to maintaining general health. For maintaining general health. Helps to prevent vitamin E deficiency. Maintains good health. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s) to support biological functions which play a key role in the maintenance of good health. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in normal growth and development. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in the maintenance of good health. Source of/An antioxidant for the maintenance of good health. Source of/An antioxidant that helps fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of/An antioxidant that protects the fat in body tissues from oxidation. Supports good health. Vitamin supplement.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
WN Pharmaceuticals Ltd
NPN or DIN-HM
80119923
Status
Active licence
Licence date
14 July 2022
Revision date
Not provided
Form
Capsule, molle
Route of administration
Orale
Application type
Générale (non traditionelle)

Source

Official Health Canada record, licence 80119923

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line